Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression Without Evidence of Early Response: A Pooled Post Hoc Analysis of the TRANSFORM Studies.
第一作者:
Ibrahim,Turkoz
第一单位:
Janssen Research & Development, LLC, Titusville, New Jersey.;Corresponding author: Ibrahim Turkoz, PhD, Department of Statistics & Decision Sciences, Janssen Research & Development, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ 08560 (ITurkoz@its.jnj.com).
作者:
医学主题词
投药, 鼻内(Administration, Intranasal);投药, 口服(Administration, Oral);成年人(Adult);抗抑郁药(Antidepressive Agents);抑郁症, 更年期(Depressive Disorder, Major);双盲法(Double-Blind Method);用药计划表(Drug Administration Schedule);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);人类(Humans);氯胺酮(Ketamine);男(雄)性(Male);中年人(Middle Aged);鼻用喷雾剂(Nasal Sprays)
DOI
10.4088/JCP.20m13800
PMID
34288609
发布时间
2021-10-07
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



